You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 1, January 3, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Arrhythmias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Left Ventricular Hypertrophy Regression and Atrial Fibrillation Incidence

Since this article does not have an abstract, we have provided the first 149 words of the full text and any section headings.

To the Editor: In their study of patients with electrocardiographic left ventricular hypertrophy (LVH), Dr Okin and colleagues1 identify an association between LVH regression as measured by the Cornell product and decreased risk of atrial fibrillation. They cite a prior study2 of this simple and low-cost electrocardiographic measure that shows a correlation with LVH.

It would be helpful to know if the authors have any information indicating whether the correlation of the Cornell measure remains intact during a treatment maneuver compared with a test such as echocardiography that was not performed in their present study. In addition, because patients often ask about the time frame after initiating hypertensive treatment in which they can expect a regression of their newly diagnosed LVH, it would be useful if the authors could provide data on the mean or median time to LVH regression after initiation of the protocol.

Financial Disclosures: None reported.

Mark H. Hyman, MD
mark@hymanmd.net
Department of Medicine
University of California
Los Angeles

1. Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA. 2006;296:1242-1248. FREE FULL TEXT
2. Okin PM, Roman MJ, Devereux RB, et al. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417-423. ABSTRACT

JAMA. 2007;297:40.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Left Ventricular Hypertrophy Regression and Atrial Fibrillation Incidence—Reply
Peter M. Okin and Richard B. Devereux
JAMA. 2007;297(1):40-41.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.